![Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC‐C‐IRMS - Iannella - 2019 - Drug Testing and Analysis - Wiley Online Library Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC‐C‐IRMS - Iannella - 2019 - Drug Testing and Analysis - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/f4d247a6-4b9b-4515-9b92-db10a99cc32f/dta2715-toc-0001-m.jpg)
Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC‐C‐IRMS - Iannella - 2019 - Drug Testing and Analysis - Wiley Online Library
![Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8c117d0f-9be9-46eb-90df-f51cbd9ae1c1/gr1.gif)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology
![Development and Clinical Application of a Prednisolone/Cortisol Assay to Determine Adherence to Maintenance Oral Prednisolone in Severe Asthma - CHEST Development and Clinical Application of a Prednisolone/Cortisol Assay to Determine Adherence to Maintenance Oral Prednisolone in Severe Asthma - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b8b56d8d-345b-42fb-a086-ac70cb6ba0a4/gr1.jpg)
Development and Clinical Application of a Prednisolone/Cortisol Assay to Determine Adherence to Maintenance Oral Prednisolone in Severe Asthma - CHEST
![Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes - Multiple Sclerosis and Related Disorders Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cd17933e-55da-48a1-aa0a-898c2073d88a/gr1.jpg)